Drug
Levomilnacipran
Levomilnacipran is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_3
2
40%
Ph phase_4
2
40%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Novel Medication as a Potential Smoking Cessation Aid
NCT02265367
unknownphase_4
Levomilnacipran in Healthy Males
NCT03249311
completedphase_3
Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
NCT02431806
completedphase_4
Trial of Levomilnacipran in Geriatric Depression
NCT02466958
completedphase_3
Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
NCT02720198
Clinical Trials (5)
Showing 5 of 5 trials
NCT02265367Not Applicable
Novel Medication as a Potential Smoking Cessation Aid
NCT03249311Phase 4
Levomilnacipran in Healthy Males
NCT02431806Phase 3
Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
NCT02466958Phase 4
Trial of Levomilnacipran in Geriatric Depression
NCT02720198Phase 3
Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5